China Diagnostic Reagent Industry Analysis Report 2015

1
Research On China Diagnostic Reagent Industry,
2015


Single User
License US 2700 No of Pages 160

Corporate User
License US 3800

• www.rnrmarketresearch.com

WEBSITE
2
Research on China Diagnostic Reagent Industry,
2015

• In-depth analysis of Diagnostic Reagent Industry
  in China, 2015 Report. After 30 years of
  development, the China's diagnostic reagent
  industry achieved a market size of nearly RMB 20
  billion in 2014, a YoY growth of 15.7. Currently
  nearly 90 downstream users of China's diagnostic
  reagent market comes from hospitals.
• There's still a huge growth potential in China's
  diagnostic reagent industry. China accounts for
  20 of total population worldwide, but only take
  up 7 of global diagnostic reagent market in
  2014. The average diagnostic reagent expense in
  China is only around 3, far below the average of
  28 in the developed countries.
• View Complete Report _at_ http//www.rnrmarketresearc
  h.com/research-on-china-diagnostic-reagent-industr
  y-2015-market-report.html

3
Research on China Diagnostic Reagent Industry,
2015

• Currently there are about 300 diagnostic reagent
  enterprises in China and the industry
  concentration is still low. Large companies in
  China include KHB, Da An Gene, Maker, HTA etc.
  Foreign brands accounts for over 50 of China's
  diagnostic reagent market in 2014, especially in
  high-end fields. The market share of domestic
  enterprises mainly comes from biochemical
  reagents.
• China has fulfilled the import substitution of
  biochemical reagents, intensified competition has
  largely squeezed the profits in this subfield.
  Chemiluminescence Immunoassay (CLIA) and
  molecular diagnosis will be the most promising
  subfields in China's diagnostic reagent industry.
• Purchase a Copy of this Report _at_
  http//www.rnrmarketresearch.com/contacts/purchase
  ?rname392985

4
Research on China Diagnostic Reagent Industry,
2015

• New Industries Biomedical Engineering Co., Ltd is
  the leading CLIA enterprise in China. Currently
  the company owns 102 chemiluminescent reagents
  and 8 models of CLIA analyzer. The company
  achieved reagents sales of RMB 331 million and
  reagents products has exported to Swiss, France,
  and Italy etc.
• Zeesan Biotech is the leading molecular diagnosis
  enterprise in China. The company achieved
  molecular diagnosis reagents sales of RMB 11.85
  million in 2014. Zeesan's products covers
  infectious disease (mainly phthisis), tumor
  (mainly leukemia) and genetic disease.
• Access Report by Chisult Insight at
  http//www.rnrmarketresearch.com/publisher/Chisult
  -Insight.html

5
Research on China Diagnostic Reagent Industry,
2015

• Data Charts
• Classification of In Vitro Diagnostic Reagents
  (by Detection Principle)2005-2013 Main Policies
  of China Diagnostic Reagent IndustryIndustry
  Chain of Diagnostic Reagent2009-2014 Market Size
  of In Vitro Diagnostics in China2014 Market
  Structure of Chinas In Vitro Diagnostic
  Reagent2010-2015 Market Size of Chinas
  Immunodiagnosis Market by ProductsDomestic
  Enterprises with Chemiluminescence Immunoassay
  (CLIA) ProductsNumbers of DLIA Diagnostic
  Reagents by Domestic Enterprises2007-2013
  Numbers of Molecular Diagnosis Project in
  China2010-2015 Market Size of Biochemical
  Diagnosis in ChinaDiagnostic Instrument
  Comparison between Domestic and Foreign
  EnterprisesCompetition Pattern of Chinas
  Diagnostic Reagent Industry Read moreInquire
  for Discount _at_ http//www.rnrmarketresearch.com/co
  ntacts/discount?rname392985

6
RnR Market ResearchRnRMarketResearch.com, An
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RNR market research library has
syndicated reports by leading market research 
publishers across the globe. For more details
contact sales_at_rnrmarketresearch.Com /
18883915441FOLLOW US
Website
www.rnrmarketresearch.com